Sirtuin Antibody Sampler Kit #9787
Product Information
Kit Usage Information
Protocols
- 2314: Western Blotting, Immunoprecipitation (Magnetic), Immunofluorescence, Flow
- 5360: Western Blotting, Immunoprecipitation (Agarose)
- 5490: Western Blotting, Immunoprecipitation (Magnetic)
- 7074: Western Blotting
- 8782: Western Blotting
- 9475: Western Blotting
- 12486: Western Blotting, Immunoprecipitation (Agarose), Immunofluorescence
- 12650: Western Blotting
Product Description
Background
SirT3 exists in human cells in two forms, including a full-length, nuclear (44 kDa) protein and a processed (28 kDa) protein found exclusively in the mitochondria (4-6). Full-length SirT3 protein is processed in the mitochondrial matrix by mitochondrial matrix processing peptidase (MMP) (5). Both full-length and processed SirT3 are active enzymes that deacetylate histone H3 at Lys9 and histone H4 at Lys16 in vitro (4). SirT3 also deacetylates Lys642 of acetyl-CoA synthetase 2 (AceCS2) and activates AceCS2 activity in the mitochondria (7).
SirT5 is localized to the mitochondria and has been implicated in the regulation of cell metabolism (8,9). Nuclear SirT6 is a chromatin-associated protein that promotes normal maintenance of genome integrity as mediated by the base excision repair (BER) pathway (10-12). Mammalian SirT7 is localized to the nucleolus and is prominently expressed in hematopoietic cells, especially myeloid progenitor cells (13). SirT7 is recruited to chromatin by sequence-specific DNA binding transcription factors such as Elk-4, where it facilitates transcriptional repression through deacetylation of histone H3 at Lys18 (14).
- Guarente, L. (1999) Nat Genet 23, 281-5.
- North, B.J. et al. (2003) Mol Cell 11, 437-44.
- Vaquero, A. et al. (2006) Genes Dev 20, 1256-61.
- Scher, M.B. et al. (2007) Genes Dev 21, 920-8.
- Schwer, B. et al. (2002) J Cell Biol 158, 647-57.
- Onyango, P. et al. (2002) Proc Natl Acad Sci U S A 99, 13653-8.
- Schwer, B. et al. (2006) Proc Natl Acad Sci U S A 103, 10224-9.
- Newman, J.C. et al. (2012) J Biol Chem 287, 42436-43.
- He, W. et al. (2012) Trends Endocrinol Metab 23, 467-76.
- Mostoslavsky, R. et al. (2006) Cell 124, 315-29.
- Liszt, G. et al. (2005) J Biol Chem 280, 21313-20.
- Michishita, E. et al. (2005) Mol Biol Cell 16, 4623-35.
- Voelter-Mahlknecht, S. et al. (2006) Int J Oncol 28, 899-908.
- Barber, M.F. et al. (2012) Nature 487, 114-8.
Alternate Names
EC 3.5.1-hSIRT1; hSIR2; hSIRT1; hSIRT2; hSIRT3; hSIRT6; Mono-ADP-ribosyltransferase sirtuin-6; NAD-dependent deacetylase sirtuin-1; NAD-dependent deacetylase sirtuin-2; NAD-dependent deacetylase sirtuin-3; NAD-dependent-deacetylase; SIR2; SIR2 L1; SIR2-like; SIR2-like protein 1; SIR2-like protein 2; SIR2-like protein 3; SIR2-like protein 6; SIR2L; SIR2L2; SIR2L3; Sir2L6; sirt; SirT1; SirT2; SirT3; SirT5; SirT6; SirT7; Sirtuin; Sirtuin 1; Sirtuin 2; Sirtuin 3; Sirtuin 5; Sirtuin 6; Sirtuin 7
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。
专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专